New Delhi, June 30 -- Building on an over 45% upside in the last one year, shares of healthcare stock Healthcare Global Enterprises can jump another 10%, predicts Axis Securities, led by strong operational efficiency, capacity expansion and sectoral tailwinds.

The domestic brokerage has a target price of Rs.600 on Healthcare Global Enterprises shares, predicting a 10% gain from the last closing price of Rs.544.

HCG is one of India's leading cancer care providers, operating 21 comprehensive centres dedicated to advanced treatment. HCG has outpaced the cancer industry, which is growing at a CAGR of 17%, the brokerage said.

"The company plans to add 900 incremental beds over the next 4 to 5 years to capitalise on emerging opportunities. S...